US Stock MarketDetailed Quotes

TGTX TG Therapeutics

Watchlist
  • 24.460
  • +0.060+0.25%
Close Aug 23 16:00 ET
  • 24.500
  • +0.040+0.16%
Post 20:02 ET
3.79BMarket Cap35.97P/E (TTM)

TG Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
357.05%73.47M
713.46%63.47M
8,290.02%233.66M
54,863.75%43.97M
176,298.94%165.82M
2,606.06%16.07M
287.05%7.8M
-58.36%2.79M
-96.55%80K
-95.37%94K
Operating revenue
357.05%73.47M
713.46%63.47M
8,290.02%233.66M
54,863.75%43.97M
176,298.94%165.82M
2,606.06%16.07M
287.05%7.8M
-58.36%2.79M
-96.55%80K
-95.37%94K
Cost of revenue
334.54%8.3M
534.89%5.44M
5,232.45%14.13M
261,700.00%7.85M
175,350.00%3.51M
8,208.70%1.91M
261.60%857K
-66.46%265K
-98.57%3K
-99.32%2K
Gross profit
360.09%65.16M
735.49%58.03M
8,611.55%219.53M
46,805.19%36.12M
176,319.57%162.31M
2,380.39%14.16M
290.44%6.95M
-57.28%2.52M
-96.35%77K
-94.71%92K
Operating expense
-4.23%56.35M
53.18%67.3M
1.81%198.9M
-6.78%48.6M
35.56%47.52M
48.91%58.84M
-36.00%43.94M
-44.29%195.36M
-45.15%52.14M
-59.64%35.06M
Selling and administrative expenses
26.29%38.79M
23.20%34.58M
75.28%122.71M
38.43%31.15M
129.89%32.77M
143.04%30.72M
36.19%28.07M
-45.35%70.01M
-30.57%22.5M
-59.16%14.25M
-General and administrative expense
26.29%38.79M
23.20%34.58M
75.28%122.71M
38.43%31.15M
129.89%32.77M
143.04%30.72M
36.19%28.07M
-45.35%70.01M
-30.57%22.5M
-59.16%14.25M
Research and development costs
-37.57%17.56M
106.19%32.72M
-39.22%76.19M
-41.12%17.45M
-29.08%14.75M
4.64%28.12M
-66.97%15.87M
-43.68%125.35M
-52.69%29.64M
-59.97%20.8M
Operating profit
119.73%8.82M
74.94%-9.27M
110.70%20.63M
76.02%-12.49M
428.30%114.78M
-14.72%-44.67M
44.68%-36.99M
44.07%-192.84M
43.99%-52.06M
58.93%-34.96M
Net non-operating interest income expense
-9.65%-3.98M
19.55%-2.29M
-23.79%-12.62M
15.06%-2.43M
-125.30%-3.71M
-20.22%-3.63M
-6.76%-2.84M
-80.76%-10.19M
-165.25%-2.86M
-58.77%-1.65M
Non-operating interest expense
9.65%3.98M
-19.55%2.29M
23.79%12.62M
-15.06%2.43M
125.30%3.71M
20.22%3.63M
6.76%2.84M
80.76%10.19M
165.25%2.86M
58.77%1.65M
Other net income (expense)
147.76%1.71M
45.70%880K
7.43%5.04M
-53.89%890K
260.53%2.86M
-52.28%691K
15.49%604K
103.51%4.7M
180.52%1.93M
49.91%793K
Other non- operating income (expenses)
147.76%1.71M
45.70%880K
7.43%5.04M
-53.89%890K
260.53%2.86M
-52.28%691K
15.49%604K
103.51%4.7M
180.52%1.93M
49.91%793K
Income before tax
113.76%6.55M
72.78%-10.68M
106.59%13.06M
73.53%-14.03M
418.08%113.93M
-17.53%-47.61M
43.15%-39.23M
43.02%-198.34M
43.22%-52.99M
58.17%-35.82M
Income tax
-328K
29K
390K
0
0
0
Net income
114.45%6.88M
72.71%-10.71M
106.39%12.67M
72.80%-14.42M
418.08%113.93M
-17.53%-47.61M
43.15%-39.23M
43.02%-198.34M
43.22%-52.99M
58.17%-35.82M
Net income continuous Operations
114.45%6.88M
72.71%-10.71M
106.39%12.67M
72.80%-14.42M
418.08%113.93M
-17.53%-47.61M
43.15%-39.23M
43.02%-198.34M
43.22%-52.99M
58.17%-35.82M
Minority interest income
Net income attributable to the parent company
114.45%6.88M
72.71%-10.71M
106.39%12.67M
72.80%-14.42M
418.08%113.93M
-17.53%-47.61M
43.15%-39.23M
43.02%-198.34M
43.22%-52.99M
58.17%-35.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
114.45%6.88M
72.71%-10.71M
106.39%12.67M
72.80%-14.42M
418.08%113.93M
-17.53%-47.61M
43.15%-39.23M
43.02%-198.34M
43.22%-52.99M
58.17%-35.82M
Basic earnings per share
114.71%0.05
75.00%-0.07
106.16%0.09
74.36%-0.1
407.69%0.8
-13.33%-0.34
45.10%-0.28
44.49%-1.46
44.29%-0.39
60.00%-0.26
Diluted earnings per share
111.76%0.04
75.00%-0.07
106.16%0.09
74.36%-0.1
380.77%0.73
-13.33%-0.34
45.10%-0.28
44.49%-1.46
44.29%-0.39
60.00%-0.26
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 357.05%73.47M713.46%63.47M8,290.02%233.66M54,863.75%43.97M176,298.94%165.82M2,606.06%16.07M287.05%7.8M-58.36%2.79M-96.55%80K-95.37%94K
Operating revenue 357.05%73.47M713.46%63.47M8,290.02%233.66M54,863.75%43.97M176,298.94%165.82M2,606.06%16.07M287.05%7.8M-58.36%2.79M-96.55%80K-95.37%94K
Cost of revenue 334.54%8.3M534.89%5.44M5,232.45%14.13M261,700.00%7.85M175,350.00%3.51M8,208.70%1.91M261.60%857K-66.46%265K-98.57%3K-99.32%2K
Gross profit 360.09%65.16M735.49%58.03M8,611.55%219.53M46,805.19%36.12M176,319.57%162.31M2,380.39%14.16M290.44%6.95M-57.28%2.52M-96.35%77K-94.71%92K
Operating expense -4.23%56.35M53.18%67.3M1.81%198.9M-6.78%48.6M35.56%47.52M48.91%58.84M-36.00%43.94M-44.29%195.36M-45.15%52.14M-59.64%35.06M
Selling and administrative expenses 26.29%38.79M23.20%34.58M75.28%122.71M38.43%31.15M129.89%32.77M143.04%30.72M36.19%28.07M-45.35%70.01M-30.57%22.5M-59.16%14.25M
-General and administrative expense 26.29%38.79M23.20%34.58M75.28%122.71M38.43%31.15M129.89%32.77M143.04%30.72M36.19%28.07M-45.35%70.01M-30.57%22.5M-59.16%14.25M
Research and development costs -37.57%17.56M106.19%32.72M-39.22%76.19M-41.12%17.45M-29.08%14.75M4.64%28.12M-66.97%15.87M-43.68%125.35M-52.69%29.64M-59.97%20.8M
Operating profit 119.73%8.82M74.94%-9.27M110.70%20.63M76.02%-12.49M428.30%114.78M-14.72%-44.67M44.68%-36.99M44.07%-192.84M43.99%-52.06M58.93%-34.96M
Net non-operating interest income expense -9.65%-3.98M19.55%-2.29M-23.79%-12.62M15.06%-2.43M-125.30%-3.71M-20.22%-3.63M-6.76%-2.84M-80.76%-10.19M-165.25%-2.86M-58.77%-1.65M
Non-operating interest expense 9.65%3.98M-19.55%2.29M23.79%12.62M-15.06%2.43M125.30%3.71M20.22%3.63M6.76%2.84M80.76%10.19M165.25%2.86M58.77%1.65M
Other net income (expense) 147.76%1.71M45.70%880K7.43%5.04M-53.89%890K260.53%2.86M-52.28%691K15.49%604K103.51%4.7M180.52%1.93M49.91%793K
Other non- operating income (expenses) 147.76%1.71M45.70%880K7.43%5.04M-53.89%890K260.53%2.86M-52.28%691K15.49%604K103.51%4.7M180.52%1.93M49.91%793K
Income before tax 113.76%6.55M72.78%-10.68M106.59%13.06M73.53%-14.03M418.08%113.93M-17.53%-47.61M43.15%-39.23M43.02%-198.34M43.22%-52.99M58.17%-35.82M
Income tax -328K29K390K000
Net income 114.45%6.88M72.71%-10.71M106.39%12.67M72.80%-14.42M418.08%113.93M-17.53%-47.61M43.15%-39.23M43.02%-198.34M43.22%-52.99M58.17%-35.82M
Net income continuous Operations 114.45%6.88M72.71%-10.71M106.39%12.67M72.80%-14.42M418.08%113.93M-17.53%-47.61M43.15%-39.23M43.02%-198.34M43.22%-52.99M58.17%-35.82M
Minority interest income
Net income attributable to the parent company 114.45%6.88M72.71%-10.71M106.39%12.67M72.80%-14.42M418.08%113.93M-17.53%-47.61M43.15%-39.23M43.02%-198.34M43.22%-52.99M58.17%-35.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 114.45%6.88M72.71%-10.71M106.39%12.67M72.80%-14.42M418.08%113.93M-17.53%-47.61M43.15%-39.23M43.02%-198.34M43.22%-52.99M58.17%-35.82M
Basic earnings per share 114.71%0.0575.00%-0.07106.16%0.0974.36%-0.1407.69%0.8-13.33%-0.3445.10%-0.2844.49%-1.4644.29%-0.3960.00%-0.26
Diluted earnings per share 111.76%0.0475.00%-0.07106.16%0.0974.36%-0.1380.77%0.73-13.33%-0.3445.10%-0.2844.49%-1.4644.29%-0.3960.00%-0.26
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg